Griese M, Schur N, Laryea M D, Bremer H J, Reinhardt D, Biggemann B
Universitäts-Kinderklinik, Düsseldorf, Federal Republic of Germany.
Eur J Pediatr. 1990 Apr;149(7):508-12. doi: 10.1007/BF01959406.
Fatty acid (FA) composition of plasma phospholipids and phospholipids extracted from peripheral mononuclear white blood cells (MNC) was investigated in 11 allergic asthmatic children (age 8.9 +/- 4.6 years), in 10 age-matched non-allergic healthy controls and in 14 allergic and non-allergic children with an acute attack of asthma, who had received prednisolone medication for 2-4 days. In allergic asthmatics eicosapentaenoic acid (20:5n-3) was significantly elevated in both plasma and MNC. The relative amount of 20:5n-3 in MNC as well as in plasma correlated positively with increasing levels of total serum IgE (P less than 0.02). The pattern of the other FAs in plasma and of MNC phospholipids did not differ between allergic asthmatic and non-allergic control children. In children with an acute attack of asthma, who had been treated with glucocorticoids (2 mg prednisolone/kg body weight for 2-4 days), distinct changes of relative FA composition of phospholipids were restricted to plasma, where some very long chain FA (22:4n-6, 22:5n-6) were elevated. No significant changes in FA from MNC phospholipids could be observed after glucocorticoid treatment. These findings may indicate a possible role of 20:5n-3, the precursor of "group 3" eicosanoids, in allergic asthmatic children.
对11名过敏性哮喘儿童(年龄8.9±4.6岁)、10名年龄匹配的非过敏性健康对照儿童以及14名患有哮喘急性发作且已接受2 - 4天泼尼松龙治疗的过敏性和非过敏性儿童,研究了血浆磷脂和从外周单核白细胞(MNC)中提取的磷脂的脂肪酸(FA)组成。在过敏性哮喘患者中,血浆和MNC中的二十碳五烯酸(20:5n - 3)均显著升高。MNC以及血浆中20:5n - 3的相对含量与血清总IgE水平升高呈正相关(P < 0.02)。过敏性哮喘儿童与非过敏性对照儿童的血浆和MNC磷脂中其他FA的模式没有差异。在接受糖皮质激素治疗(2mg泼尼松龙/ kg体重,持续2 - 4天)的哮喘急性发作儿童中,磷脂相对FA组成的明显变化仅限于血浆,其中一些极长链FA(22:4n - 6、22:5n - 6)升高。糖皮质激素治疗后,未观察到MNC磷脂中FA有显著变化。这些发现可能表明“3类”类二十烷酸的前体20:5n - 3在过敏性哮喘儿童中可能发挥作用。